We are pleased to announce that we have secured a ¬£40 million investment to support the rapid growth of our repeat prescription¬†service.
The cash injection follows a phenomenal period of high growth and we‚Äôre delighted to have secured investment from healthcare specialist investor G Square Capital and our current investor BGF, which was also involved in the¬†financing.
We will use the capital to continue to bring much needed innovation to healthcare and maintain the same high level of service as we grow.
We believe digital transformation is essential to improving patient access to healthcare and easing the strain on the NHS. We are passionate about showing patients how technology can help simplify and improve the way they manage their health & medication.
We¬†are on a mission to help improve patient outcome in partnership with the NHS by managing repeat prescriptions from request to delivery, and we thank all our investors, our staff and our patients who are on the journey with¬†us.